Zobrazeno 1 - 10 of 1 666 pro vyhledávání: '"A Gasperetti"'
1
Akademický článek
A new approach to a wicked problem: development of a cross-sector community-centered learning network to tackle childhood food inequity
Autor: Aaron M. Schuh, Christopher Alexander, Kristen Gasperetti, Michelle C. Gorecki, Kimberly Cutler, Charles Hoffman, Robert S. Kahn, Chika Okano, Carley L. Riley
Publikováno v: Frontiers in Public Health, Vol 12 (2024)
Food insecurity is a complex societal problem that disproportionately impacts households with children and those led by minoritized populations, with negative impacts on health across the life course. System to Achieve Food Equity adapted the learnin
Externí odkaz: https://doaj.org/article/b7a6001bc6f84956bb404a3b1d600570
Zobrazit plný text záznamu
2
Akademický článek
From surgery to functional capacity: muscle strength modifications in women post sleeve gastrectomy
Autor: Valentina Bullo, Davide Pavan, Stefano Gobbo, Alessandro Bortoletto, Lucia Cugusi, Andrea Di Blasio, Roberto Pippi, David Cruz-Diaz, Danilo Sales Bocalini, Andrea Gasperetti, Roberto Vettor, Andrea Ermolao, Marco Bergamin
Publikováno v: BMC Sports Science, Medicine and Rehabilitation, Vol 16, Iss 1, Pp 1-8 (2024)
Abstract Background Severe obesity is characterized by excessive accumulation of fat generating a general health decline. Multidisciplinary treatment of obesity leads to significant weight loss in a few patients; therefore, many incur bariatric surge
Externí odkaz: https://doaj.org/article/b26fe6b54acc4edfa493af2ee0a7e64c
Zobrazit plný text záznamu
4
Akademický článek
Eighteen‐Month Real‐World Experience Using Mavacamten for Treatment of Obstructive Hypertrophic Cardiomyopathy in a Racially Diverse Population
Autor: Diego Ramonfaur, Alessio Gasperetti, Victoria E. Blake, Bryana Rivers, Ali A. Kassamali, Edward K. Kasper, Lili A. Barouch, Katherine C. Wu, Jose A. Madrazo, Richard T. Carrick
Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
Background Patients with obstructive hypertrophic cardiomyopathy have increased symptomatic burden. Mavacamten was recently approved for treatment of obstructive hypertrophic cardiomyopathy based on 2 randomized controlled trials. However, its use un
Externí odkaz: https://doaj.org/article/d26afaf760874136964d091cc4c03fcc
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje